Juvenile Diabetes

Download PDF

Recent Publications on Juvenile Diabetes:
Islet transplantation in patients with autoimmune diabetes induces homeostatic cytokines that expand autoreactive memory T cells. Successful transplantation requires the prevention of allograft rejection...	2nd July, 2008	Immunology of Diabetes Unit and Clinical Transplant Unit,	J Clin Invest. 2008 May;118(5):1806-14. DOI Direct Link
Acute bilateral dense cortical cataracts as a first manifestation of juvenile diabetes mellitus in a 12-year-old girl. A 12-year-old girl with no previous visual complaints or diagnosis of...	24th June, 2008	Eye Clinic, Vakif Gureba Training and Research Hospital, Istanbul, Turkey.	J Pediatr Ophthalmol Strabismus. 2008 May-Jun;45(3):177-8.
Oxidative stress as a major culprit in kidney disease in diabetes. It is postulated that localized tissue oxidative stress is a key component...	31st May, 2008	Juvenile Diabetes Research Foundation Albert Einstein Centre for Diabetes	Diabetes. 2008 Jun;57(6):1446-54. DOI Direct Link
Clinical review: The role of advanced glycation end products in progression and complications of diabetes. CONTEXT: Diabetic complications appear to be multifactorial in origin, but...	28th May, 2008	Albert Einstein Juvenile Diabetes Research Foundation, Centre for Diabetes	J Clin Endocrinol Metab. 2008 Apr;93(4):1143-52. Epub 2008 Jan 8. DOI Direct Link
Four-shell ellipsoidal model employing multipole expansion in ellipsoidal coordinates. Although the head is more closely represented as an ellipsoid than a...	20th May, 2008	The Max McGee National Research Center For Juvenile Diabetes, Medical	Med Biol Eng Comput. 2008 May 17;. DOI Direct Link
→View more research publications.

BioNews Results for Juvenile Diabetes:
EpiVax Receives $600,000 Grant to develop treatment for Diabetes from National Institutes of Health	DiGiTAL50:  Jul 9 2008 2:11PM Matching: juvenile diabetes
NIH awards EpiVax $600K for diabetes treatment research	Mass High Tech:  Jul 8 2008 11:15PM Matching: juvenile diabetes
EpiVax Receives $600,000 Grant to develop treatment for Diabetes from National Institutes of Health	Genetic Engineering News:  Jul 8 2008 1:23PM Matching: juvenile diabetes
EpiVax Receives $600,000 Grant to develop treatment for Diabetes from National Institutes of Health	Forbes.com:  Jul 8 2008 1:11PM Matching: juvenile diabetes
EpiVax Receives $600,000 Grant to develop treatment for Diabetes from National Institutes of Health	Earthtimes.org:  Jul 8 2008 1:22PM Matching: juvenile diabetes
Promote your company here: BioNewsCast - Press Release Distribution	→View more news.

Juvenile Diabetes Clinical Trials:
Trial of Intranasal Insulin in Children and Young Adults at Risk of Type 1 Diabetes	Type 1 Diabetes
Prevalence of Nocturnal Hypoglycemia in Children on a Type 1 Diabetes (TID) Insulin Regimen Using a Continuous Glucose Monitoring System (CGMS)	Nocturnal Hypoglycemia;   Type 1 Diabetes
TRIGR - Primary Prevention Study for Type 1 Diabetes in Children at Risk	Diabetes Mellitus, Type 1
Umbilical Cord Blood Infusion to Treat Type 1 Diabetes	Type 1 Diabetes Mellitus
TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)	Type 1 Diabetes Mellitus
→View more trials.

Juvenile Diabetes Patents:
US Patent No.	Title
7211594	Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith
7253176	Immunosuppressive effects of 8-substituted xanthine derivatives
7253283	Tricyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-.kappa.B activity and use thereof
7258857	Rage-related methods for treating inflammation
7270997	Coxsackievirus B4 expression vectors and uses thereof
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Juvenile Diabetes scientists - we have details of around 135 individuals working on Juvenile Diabetes .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.